Furthermore, it addresses the FDA’s communications Along with the applicant, the retention of documents that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer possession of the SE report back to a completely new applicant and Digital submission on the SE rep